Publications

Found 2 results
Filters: Author is D. Kang  [Clear All Filters]
2012
G. - W. Lee, Kim, J. - Y., Koh, E. - H., Kang, D., Choi, D. S., Maeng, K. - Y., and Lee, J. - S., Plasma human mammaglobin mRNA associated with poor outcome in patients with breast cancer, vol. 11, pp. 4034-4042, 2012.
Bae JM, Won YJ, Jung KW and Park JG (2002). Annual report of the Korea central cancer registry program 2000: Based on registered data from 131 hospitals. Cancer Res. Treat. 34: 77-83.   Benoy IH, Elst H, Philips M, Wuyts H, et al. (2006). Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer. Br. J. Cancer 94: 672-680. PMid:16495933 PMCid:2361203   Braun S, Cevatli BS, Assemi C, Janni W, et al. (2001). Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. J. Clin. Oncol. 19: 1468-1475. PMid:11230493   Ferrucci PF, Rabascio C, Mazzetta C, Cocorocchio E, et al. (2004). Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer. Clin. Cancer Res. 10: 6039-6046. http://dx.doi.org/10.1158/1078-0432.CCR-03-0453 PMid:15447988   Fortunato L, Mascaro A, Baldi A, Farina M, et al. (2009). Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer. Ann. Surg. Oncol. 16: 3010-3019. http://dx.doi.org/10.1245/s10434-009-0619-x PMid:19641970   Gormally E, Caboux E, Vineis P and Hainaut P (2007). Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat. Res. 635: 105-117. http://dx.doi.org/10.1016/j.mrrev.2006.11.002 PMid:17257890   Grunewald K, Haun M, Urbanek M, Fiegl M, et al. (2000). Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19. Lab. Invest. 80: 1071-1077. http://dx.doi.org/10.1038/labinvest.3780112 PMid:10908152   Gruvberger S, Ringner M, Chen Y, Panavally S, et al. (2001). Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61: 5979-5984. PMid:11507038   Jung KW, Park S, Kong HJ, Won YJ, et al. (2011). Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res. Treat. 43: 1-11. http://dx.doi.org/10.4143/crt.2011.43.1.1 PMid:21509157 PMCid:3072529   Keen JC and Davidson NE (2003). The biology of breast carcinoma. Cancer 97: 825-833. http://dx.doi.org/10.1002/cncr.11126 PMid:12548582   Núñez-Villar MJ, Martinez-Arribas F, Pollan M, Lucas AR, et al. (2003). Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype. Breast Cancer Res. 5: R65-R70. http://dx.doi.org/10.1186/bcr587 PMid:12793902 PMCid:165002   Roncella S, Ferro P, Bacigalupo B, Pronzato P, et al. (2005). Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood. J. Exp. Clin. Cancer Res. 24: 265-271. PMid:16110760   Span PN, Waanders E, Manders P, Heuvel JJ, et al. (2004). Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time. J. Clin. Oncol. 22: 691-698. http://dx.doi.org/10.1200/JCO.2004.01.072 PMid:14966093   Stacker SA, Achen MG, Jussila L, Baldwin ME, et al. (2002). Lymphangiogenesis and cancer metastasis. Nat. Rev. Cancer 2: 573-583. http://dx.doi.org/10.1038/nrc863 PMid:12154350   Tafreshi NK, Enkemann SA, Bui MM, Lloyd MC, et al. (2011). A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes. Cancer Res. 71: 1050-1059. http://dx.doi.org/10.1158/0008-5472.CAN-10-3091 PMid:21169406   Watson MA and Fleming TP (1996). Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res. 56: 860-865. PMid:8631025   Zach O, Kasparu H, Krieger O, Hehenwarter W, et al. (1999). Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J. Clin. Oncol. 17: 2015-2019. PMid:10561252   Zehentner BK, Persing DH, Deme A, Toure P, et al. (2004). Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA. Clin. Chem. 50: 2069-2076. http://dx.doi.org/10.1373/clinchem.2004.038687 PMid:15375015 PMCid:1482781